Brian Piper

PRLD

Brian Piper serves as Chief Financial Officer at Prelude Therapeutics Incorporated (PRLD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$563.4K

Net Position

Net Seller

$563.4K

Companies Traded

PRLD

Active Period

May 2021 – Aug 2021

2 total trades

Most Recent

Sell PRLD

Aug 27, 2021 · $277.8K

Brian Piper's Insider Trading at Prelude Therapeutics Incorporated (PRLD)

Buys

0 · $0.00

Sells

2 · $563.4K

Total Shares Bought

Total Shares Sold

16,666

PRLD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 27, 2021	Sell	8,333	$33.34	$277.8K	6,233
May 27, 2021	Sell	8,333	$34.27	$285.5K	5,223

Related Insiders

David P Bonita

director, 10 percent owner:

PRLDBuy · Apr 23, 2026

ORBIMED ADVISORS LLC

director, 10 percent owner:

PRLDBuy · Apr 23, 2026

BAKER BROS. ADVISORS LP

director, 10 percent owner:

PRLDBuy · Apr 22, 2026

Jane Huang

President, CMO

PRLDSell · Oct 4, 2025

Explore More Insider Trading Data

PRLD Insider Trading Activity

View all insider trades at Prelude Therapeutics Incorporated

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity